DETERMINATION OF PINDOLOL IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引：27

作者：

BANGAH, M ^{[1
]}

JACKMAN, G ^{[1
]}

BOBIK, A ^{[1
]}

机构：

[1] BAKER MED RES INST,PRAHRAN,VIC 3181,AUSTRALIA

来源：

JOURNAL OF CHROMATOGRAPHY | 1980年 / 183卷 / 02期

关键词：

D O I：

10.1016/S0378-4347(00)81703-X

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

引用

页码：255 / 259

页数：5

共 7 条

[1] RELATIONSHIP OF PLASMA-LEVELS OF PINDOLOL IN HYPERTENSIVE PATIENTS TO EFFECTS ON BLOOD-PRESSURE, PLASMA-RENIN AND PLASMA NORADRENALINE LEVELS [J].

ANAVEKAR, SN ;

LOUIS, WJ ;

MORGAN, TO ;

DOYLE, AE ;

JOHNSTON, CI .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1975, 2 (03) :203-212

[2] PHARMACOKINETICS OF PINDOLOL IN MAN [J].

GUGLER, R ;

HEROLD, W ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :17-24

[3] PINDOLOL PHARMACOKINETICS IN RELATION TO TIME COURSE OF INHIBITION OF EXERCISE TACHYCARDIA [J].

JENNINGS, GL ;

BOBIK, A ;

FAGAN, ET ;

KORNER, PI .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (03) :245-256

[4] A POTENT BETA-ADRENORECEPTOR BLOCKING DRUG - 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)INDOLE [J].

MOORE, GE ;

ODONNELL, SR .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1970, 22 (03) :180-+

[5] USE OF PRINDOLOL (VISKEN) IN TREATMENT OF HYPERTENSION [J].

MORGAN, TO ;

DOYLE, AE ;

LOUIS, WJ ;

DAWBORN, JK .

MEDICAL JOURNAL OF AUSTRALIA, 1972, 2 (06) :309-&

[6] PROLONGED ACTION OF PINDOLOL [J].

NIGAM, PD ;

MALHOTRA, AS .

BRITISH MEDICAL JOURNAL, 1973, 1 (5855) :742-743

[7] A METHOD FOR FLUORIMETRIC DETERMINATION OF 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)-INDOLE (LB46), A BETA-BLOCKING AGENT, IN PLASMA AND URINE [J].

PACHA, WL .

EXPERIENTIA, 1969, 25 (08) :802-&

← 1 →